"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...

Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first.

Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now.

Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix ...

In this webinar, researchers discuss using and improving next-generation gene editing approaches for targeted, accurate, and ...

Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...

The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...

India's first gene-edited sheep recently turned a year old and researchers who developed it say it's doing well. Born on 16 December last year in Indian-administered Kashmir, the sheep has been named ...